new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Enanta Pharmaceuticals Inc patents

Recent patent applications related to Enanta Pharmaceuticals Inc. Enanta Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Enanta Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Enanta Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Enanta Pharmaceuticals Inc-related inventors




Date Enanta Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
01/26/17Hepatitis b antiviral agents
01/26/17Benzodiazepine derivatives as rsv inhibitors
01/19/17Hepatitis b antiviral agents
11/17/16Hepatitis b antiviral agents
10/06/16Hepatitis b antiviral agents
10/06/16Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
08/11/16Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
08/04/16Hepatitis c virus inhibitors
06/30/16Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
06/23/16Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
06/09/16Nucleoside and nucleotide derivatives
05/26/16Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
05/26/16Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
05/26/16Macrocyclic proline derived hcv serine protease inhibitors
05/19/16Novel cyclosporin analogues for preventing or treating hepatitis c infection
05/12/16Deuterated nucleoside/tide derivatives
05/12/16Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
05/12/16Novel cyclosporin analogues for preventing or treating hepatitis c infection
03/03/16Nucleoside and nucleotide derivatives
02/25/16Cyclosporin analogues for preventing or treating hepatitis c infection
02/26/15Novel cyclosporin analogues for preventing or treating hepatitis c infection
11/20/14Novel benzimidazole derivatives
10/23/14Processes for the preparation of novel benzimidazole derivatives
10/16/14Hepatitis c virus inhibitors
08/07/145, 6-d2 uridine nucleoside/tide derivatives
07/10/14Novel benzimidazole derivatives
07/10/14Macrocyclic proline derived hcv serine protease inhibitors
07/03/146,11-bridged biaryl macrolides
07/03/14Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
06/05/14Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis c infection
05/15/146-11 bicyclic ketolide derivatives
03/13/14Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
11/28/13Macrocyclic nucleoside phosphoramidate derivatives
11/07/13Linked dibenzimidazole antivirals
09/05/13Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides
07/18/13Cyclosporin analogues for preventing or treating hepatitis c infection
06/27/136,11-bridged biaryl macrolides
06/06/13Quinoxaline-containing compounds as hepatitis c virus inhibitors
03/29/12Hepatitis c virus inhibitors
03/29/12Novel benzimidazole derivatives
03/22/12Macrocyclic proline derived hcv serine protease inhibitors
09/08/11Combination pharmaceutical agents as inhibitors of hcv replication
02/18/106-11 bridged oxime erythromycin derivatives







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Enanta Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Enanta Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';